Small market cap companies more dependent on COVID-19 pipeline drug: GlobalData
The small-cap bio/pharma companies without a COVID-19 drug, on average, declined by 19.4 per cent
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.